Romosozumab versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis through a Grade Analysis of Evidence.
Aixian TianHaobo JiaShan ZhuBin LuYan LiJianxiong MaXin-Long MaPublished in: Orthopaedic surgery (2021)
Based on the available studies, our current results demonstrate that romosozumab was better than teriparatide both in terms of efficacy and side effects.